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633hypertension, a more precise inﬂuence of total adi-
posity may be obtained. This is important because
the cardiometabolic risk of many patients may be
underestimated when using BMI because it cannot
always properly discriminate the risk of chronic
disease at the individual level (4).
Data from the study by Chandra et al. (1) reinforce
the notion that focusing on body composition, rather
than BMI, when screening for obesity and overweight
may be helpful to better estimate cardiometabolic
risk in clinical practice (5).*Javier Gómez-Ambrosi, PhD
Victoria Catalán, PhD
Amaia Rodríguez, PhD
Javier Salvador, MD, PhD
Gema Frühbeck, RNutr, MD, PhD
*Metabolic Research Laboratory
Clínica Universidad de Navarra - CIBERobn - IDISNA
Irunlarrea 1
31008 Pamplona
Spain
E-mail: jagomez@unav.es
http://dx.doi.org/10.1016/j.jacc.2014.09.092
RE F E RENCE S
1. Chandra A, Neeland IJ, Berry JD, et al. The relationship of body mass and
fat distribution with incident hypertension: observations from the Dallas Heart
Study. J Am Coll Cardiol 2014;64:997–1002.
2. Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body mass index classiﬁcation
misses subjects with increased cardiometabolic risk factors related to elevated
adiposity. Int J Obes 2012;36:286–94.
3. Barreira TV, Staiano AE, Harrington DM, et al. Anthropometric correlates of
total body fat, abdominal adiposity, and cardiovascular disease risk factors in a
biracial sample of men and women. Mayo Clin Proc 2012;87:452–60.
4. Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body adiposity and type 2
diabetes: increased risk with a high body fat percentage even having a normal
BMI. Obesity 2011;19:1439–44.
5. Frühbeck G. Obesity: screening for the evident in obesity. Nat Rev Endo-
crinol 2012;8:570–2.REPLY: Does Body Adiposity Better Predict
Obesity-Associated Cardiometabolic Risk
Than Body Mass Index?We thank Dr. Gómez-Ambrosi and colleagues for their
insights regarding our paper (1). We agree completely
with the notion that body mass index (BMI) has lim-
itations with regard to measuring adiposity, although
it certainly remains the most clinically used measure
of adiposity. For this reason, we believed it was an
important component to add to our multivariate
modeling.
As suggested, we did have access to data on
total body fat as measured by dual-energy x-ray ab-
sorptiometry; however, because this is not acommonly used measure of total adiposity, we did
not choose to use it in our multivariate modeling.
Nonetheless, total fat mass determined by dual-
energy x-ray absorptiometry was, like body mass
index, found to be highly associated with the devel-
opment of hypertension after adjusting for age,
baseline systolic blood pressure, sex, race/ethnicity,
history of smoking, and diabetes mellitus (relative
risk [RR]: 1.27; 95% conﬁdence interval [CI]: 1.14 to
1.41; p < 0.0001). However, as in the original analysis,
this association is attenuated when visceral adipose
tissue is included in the model (RR: 1.20; 95% CI: 0.89
to 1.62; p ¼ 0.24) while visceral adipose tissue re-
mains signiﬁcant (RR: 1.20; 95% CI: 1.04 to 1.39;
p ¼ 0.012). Thus, despite the addition of a more ac-
curate measure of total adipose mass, our conclusion
appears to remain the same, namely that visceral
adipose tissue is the adipose tissue depot most asso-
ciated with incident hypertension.Alvin Chandra, MD
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Studies of Culprit Lesions
Before MIWe read with interest the excellent editorial by Nar-
ula and Kovacic (1). This letter is to clarify issues in
the ﬁrst paragraph about our serial angiographic
studies of culprit lesions before myocardial infarction
(MI) (2,3).
We agree that the culprit occlusion causing an
MI contains usually substantial atherosclerosis with
superimposed thrombus. Furthermore, pathological
and cross-sectional intracoronary imaging shows that
the culprit usually produces a high-grade stenosis
(>90%). However, these observations are not incon-
sistent with our reports that the culprit frequently did
not contain a signiﬁcant angiographic stenosis when
evaluated before MI (2,3). The conclusions of our
